Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Randomized Controlled Trial

Comparative Study

Observational Study

Systematic Review

Research Support, Non-U.S. Gov't

Clinical Trial, Phase III

Meta-Analysis

Clinical Trial, Phase II

Clinical Trial

Clinical Trial Protocol

Multicenter Study

Scoping Review

Controlled Clinical Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Hyperthermic Intraperitoneal Chemotherapy""[mesh_terms]

27 Results

Searching titles within these results

A phase I, nonrandomized controlled trial demonstrating the novel technique of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy utilizing warm humidified carbon dioxide insufflation.

Celine Garrett, Daniel Steffens, Nabila Ansari, Cherry Koh

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2021;23(6):1573-1578

Full Text

Abstract

Imaging in Hyperthermic Intraperitoneal Chemotherapy.

James A Brink, James C Cusack, Onofrio A Catalano, Avinash R Kambadakone, Shravya Srinivas Rao, Nikitha Uma Baskaran, Jinjin Cao

Radiographics : a review publication of the Radiological Society of North America, Inc 2025;45(5):e240124

Full Text

Abstract

Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study.

Annika Kurreck, Felix Gronau, Miguel Enrique Alberto Vilchez, Wiltrud Abels, Philipp Enghard, Andreas Brandl, Roland Francis, Bettina Föhre, Christian Lojewski, Johann Pratschke, Peter Thuss-Patience, Dominik Modest, Beate Rau, Linda Feldbrügge

Annals of surgical oncology 2021;29(1):152-162

Free Full Text

Abstract

Is there a role for hyperthermic intraperitoneal chemotherapy in ovarian cancer?

Aaron M Praiss, Lea A Moukarzel, Oliver Zivanovic

Current opinion in obstetrics & gynecology 2023;35(1):21-26

Free Full Text

Abstract

Randomized Controlled Trial Investigating Perioperative Immunonutrition for Patients Undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Grace Hwei Ching Tan, Claramae Shulyn Chia, Jolene Si Min Wong, Whee Sze Ong, Hong-Yuan Zhu, Chin-Ann Johnny Ong, Melissa Ching Ching Teo

Annals of surgical oncology 2023;30(2):777-789

Full Text

Abstract

Hyperthermic Intraperitoneal Chemotherapy May Damage Renal Function and Cause Serum Electrolyte Disturbance: A Retrospective Observational Study.

Zhiyuan Yu, Xudong Zhao, Shuzhong Qiu, Sixin Zhou, Peiyu Li, Na Liu

Surgical laparoscopy, endoscopy & percutaneous techniques 2023;33(3):302-309

Full Text

Abstract

A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology.

Laura M Chambers, Anthony B Costales, Katie Crean-Tate, Michelle Kuznicki, Molly Morton, Max Horowitz, Tiffany Jagielo, Peter G Rose, Chad Michener, Roberto Vargas, Robert Debernardo

Gynecologic oncology 2021;158(3):794-802

Full Text

Abstract

Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.

Michelle V Dietz, Katrien L A Quintelier, Job P van Kooten, Nadine L de Boer, Madelief Vink, Alexandra R M Brandt-Kerkhof, Cornelis Verhoef, Yvan Saeys, Joachim G J V Aerts, Marcella Willemsen, Sofie Van Gassen, Eva V E Madsen

Journal for immunotherapy of cancer 2023;11(8):e007070

Free Full Text

Abstract

Prehabilitation to improve postoperative outcomes in patients with peritoneal carcinomatosis undergoing hyperthermic intraperitoneal chemotherapy (HIPEC): A scoping review.

D Strijker, W J H J Meijerink, A J A Bremers, P de Reuver, C J H M van Laarhoven, B van den Heuvel

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022;48(3):657-665

Free Full Text

Abstract

Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer.

Joyce Y Wang, Maya Gross, Renata R Urban, Soledad Jorge

Current treatment options in oncology 2024;25(3):313-329

Full Text

Abstract

Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study.

Loek A W de Jong, Fortuné M K Elekonawo, Marie Lambert, Jan Marie de Gooyer, Henk M W Verheul, David M Burger, Johannes H W de Wilt, Etienne Chatelut, Rob Ter Heine, Philip R de Reuver, Andre J A Bremers, Nielka P van Erp

Cancer chemotherapy and pharmacology 2021;86(1):141-150

Free Full Text

Abstract

Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A systematic review.

Reshma Ambulkar, Sohan Lal Solanki, Bindiya Salunke, Gauri Gangakhedkar, Deepali V Kuberkar, Aditi Bhatt

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024;50(12):108622

Full Text

Abstract

Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial.

Marc Pocard, Frédéric Guyon, Jean-Marc Guilloit, Frédéric Marchal, Laurence Gladieff, Sylvaine Durand-Fontanier, Loïc Campion, Jean-Marc Classe, François Quenet, Elodie Martin, Bernard Asselain, Isabelle Ray-Coquard, Olivier Glehen, Emilie Brument, Dominique Berton, Florence Joly, Pierre Meeus, Delphine Hudry, Romuald Wernert, Gilles Houvenaeghel, Anne-Sophie Bats, Fabrice Lecuru, Gwenaël Ferron, Cécile Brigand, Gabriel Liberale, Constantin Georgeac, Sébastien Gouy, Cristina Costan, Jean-Marc Rousselet, Lara de Guerké, Naoual Bakrin

The Lancet. Oncology 2024;25(12):1551-1562

Full Text

Abstract

Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis.

Yu Xia, He Wang, Jing Zhang, Yongjun Wang

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2023;40(1):2165729

Free Full Text

Abstract

The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorectal cancer: A systematic review and meta-analysis.

Andrea Di Giorgio, Stefano Rotolo, Marco Cintoni, Emanuele Rinninella, Gabriele Pulcini, Carlo Alberto Schena, Federica Ferracci, Futura Grassi, Pauline Raoul, Rossana Moroni, Fabio Pacelli, Antonio Gasbarrini, Maria Cristina Mele

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022;48(3):649-656

Full Text

Abstract

Results: 1 – 15 / 27

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Hyperthermic Intraperitoneal Chemotherapy""[mesh_terms]

A phase I, nonrandomized controlled trial demonstrating the novel technique of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy utilizing warm humidified carbon dioxide insufflation.

Imaging in Hyperthermic Intraperitoneal Chemotherapy.

Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study.

Is there a role for hyperthermic intraperitoneal chemotherapy in ovarian cancer?

Randomized Controlled Trial Investigating Perioperative Immunonutrition for Patients Undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Hyperthermic Intraperitoneal Chemotherapy May Damage Renal Function and Cause Serum Electrolyte Disturbance: A Retrospective Observational Study.

A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology.

Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.

Prehabilitation to improve postoperative outcomes in patients with peritoneal carcinomatosis undergoing hyperthermic intraperitoneal chemotherapy (HIPEC): A scoping review.

Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer.

Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study.

Acute kidney injury after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - A systematic review.

Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial.

Prognostic value and adverse events of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in primary advanced and platinum-sensitive recurrent epithelial ovarian cancer: a systematic review and meta-analysis.

The prognostic value of skeletal muscle index on clinical and survival outcomes after cytoreduction and HIPEC for peritoneal metastases from colorectal cancer: A systematic review and meta-analysis.

Results for

""Hyperthermic Intraperitoneal Chemotherapy""[mesh_terms]